Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.

Sung W. Lee, Xia Wang, Namita Roy Chowdhury, Jayanta Roy-Chowdhury

Research output: Contribution to journalReview article

52 Scopus citations

Abstract

Over three decades of research in experimental animals and several clinical trials have brought us to the threshold of hepatocyte transplantation for the treatment of acute and chronic liver failure, and inherited metabolic disorders. However, more extensive clinical studies and routine clinical application are hampered by the shortage of good quality of donor cells. To overcome these hurdles, current research has focused on the search for alternatives to adult primary hepatocytes, such as liver cell progenitors, fetal hepatoblasts, embryonic, bone marrow or umbilical cord blood stem cells and conditionally immortalized hepatocytes. Cross-species hepatocyte transplantation is also being explored. It is hoped that ongoing research will permit the application of hepatocyte transplantation to the treatment of a wide array of liver diseases.

Original languageEnglish (US)
Pages (from-to)48-53
Number of pages6
JournalAnnals of hepatology : official journal of the Mexican Association of Hepatology
Volume3
Issue number2
StatePublished - Jan 1 2004

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Hepatocyte transplantation: state of the art and strategies for overcoming existing hurdles.'. Together they form a unique fingerprint.

  • Cite this